Navigation Links
American Medical Association Clears Path for Adenoviral Conjunctivitis - 'Pink Eye' - Detector
Date:11/7/2007

SARASOTA, Fla., Nov. 7 /PRNewswire/ -- Rapid Pathogen Screening Inc., (RPS) -- a leading developer of point-of-care diagnostic devices for ocular diseases -- announced today that the American Medical Association will issue a new Current Procedural Terminology (CPT) code that will cover the RPS Adeno Detector(TM), effective January 1, 2008. CPT Code 87809 -- a code for "Infectious agent antigen detection by immunoassay with direct optical observation; Adenovirus" -- will cover the RPS Adeno Detector(TM).

The RPS Adeno Detector(TM) is the first true point-of-care test available for conjunctivitis -- more commonly known as "pink eye." Cleared by the Food and Drug Administration (FDA) and waived under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), this test is highly sensitive and specific, and it provides a definitive result in 10 minutes. The publication of this CPT code will expand the use of the RPS Adeno Detector(TM) and equip health care providers with this necessary tool to make an accurate laboratory confirmation of adenoviral conjunctivitis at the time of the patient exam.

"The creation of a new CPT code reflects the value that the RPS Adeno Detector(TM) provides to the patient, the clinician and the healthcare system at large," stated Robert Sambursky, MD, Chief Medical Officer of RPS. "With the CPT code, clinicians may use the RPS Adeno Detector(TM) to accurately diagnose and treat cases of acute conjunctivitis. This will not only result in better patient care; it also will save millions in health care dollars. If all cases of acute conjunctivitis were diagnosed with the RPS Adeno Detector(TM), the Health Economics Consulting Group, LLC (HECG) estimates that the U.S. healthcare system would save more than $460 million each year."

The RPS Adeno Detector(TM) not only allows for accurate and early diagnosis of pink eye thereby mitigating the spread of this often contagious disease, but it also reduces the over-prescription of antibiotics -- to which Americans have become more resistant as documented by recent medical reports.

About the RPS Adeno Detector(TM)

The RPS Adeno Detector(TM) is the first in a family of RPS point-of-care diagnostic devices. As a rapid, in-office, immunodiagnostic test for detecting the presence of adenoviral antigens, the RPS Adeno Detector(TM) meets the criteria established within the October 2006 Preferred Practice Pattern(TM) on Conjunctivitis from the American Academy of Ophthalmology. The test is currently being used as point-of-care test in many optometry and ophthalmology offices, family practice and pediatric offices, as well as on military bases and other centers for care across the United States.

About the Code

CPT codes are published by the American Medical Association, and each code is a five digit numeric code used to provide uniform language that accurately describes medical, surgical, radiology, laboratory, anesthesiology, and evaluation/management services of physicians, hospitals, and other health care providers. There are approximately 7,800 CPT codes.

About RPS:

To learn more about RPS, please visit: http://www.rps-tests.com

Contact: Dan Maloy

Rapid Pathogen Screening, Inc.

941-556-1855

maloy@rps-tests.com

http://www.rps-tests.com


'/>"/>
SOURCE Rapid Pathogen Screening Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... ... Maury Regional Health has announced a large-scale adoption of AccuVein vein visualization ... Regional Medical Center is making vein visualization part of their standard of care. , ... importantly, helps our staff members locate a vein that will provide good access to ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment ... clinics in all 29 Indian states—bringing the country one step closer to eliminating clubfoot ... the nonprofit organization is on track to enroll 10,000 children in the clubfoot treatment ...
(Date:8/16/2017)... ... , ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has ... viewers in a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their ... Ray disc in 2018. Proceeds will be going to further health research. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
Breaking Medicine Technology: